Zhuhai Trinomab Pharmaceutical Co., Ltd.SSE: 688806

(688806)"ZHUHAI TRINOMAB PHARMACEUTICAL CO., LTD."Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2026

· Issued by Zhuhai Trinomab Pharmaceutical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Stock code 688806 · · 6 pages · Chinese

Summary by 6ix AI

The meeting included the election of non-independent and independent directors, with all proposals passing successfully. The meeting was attended by a significant number of shareholders, representing a substantial portion of the voting rights. The meeting's procedures were confirmed to comply with legal requirements, and the results were validated by legal counsel.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Zhuhai Trinomab Pharmaceutical Co., Ltd. on 6ix